Sign in

Back to the bill

88th General Assembly · Funnel one-pager · Monday, November 9, 2026

SF 2216: Relating to insurance coverage for diagnostic breast cancer examinations and prescription drugs used in the treatment of stage IV cancer, and including applicability provisions

Died when the session ended · The 2020 session adjourned on June 14, 2020, the General Assembly’s last regular session. Bills that didn’t pass both chambers died.

Sponsors

Not listed

Cost

No fiscal note

Senate subcommittee · named February 12, 2020

  • Sen. Amy Sinclair (R) · amy.sinclair@legis.iowa.gov
  • Sen. Carrie Koelker (R) · carrie.koelker@legis.iowa.gov
  • Sen. Liz Mathis (D)

Lobbying · 3 for, 0 against

For: Genentech, Inc., A Member of the Roche Group; Iowa Primary Care Association; League of Women Voters of Iowa

In plain words

  1. February 10, 2020Filed in the Senate and sent to the Commerce committee
  2. February 12, 2020Senate subcommittee named: Sinclair, Koelker and Mathis

From public records at legis.iowa.gov, compiled by Funnel (iowafunnel.com), an independent, nonpartisan site. Current as of Monday, November 9, 2026. https://iowafunnel.com/bills/88/SF2216